TR200200169T2 - IL-18 inhibitörlerinin kullanımı. - Google Patents

IL-18 inhibitörlerinin kullanımı.

Info

Publication number
TR200200169T2
TR200200169T2 TR2002/00169T TR200200169T TR200200169T2 TR 200200169 T2 TR200200169 T2 TR 200200169T2 TR 2002/00169 T TR2002/00169 T TR 2002/00169T TR 200200169 T TR200200169 T TR 200200169T TR 200200169 T2 TR200200169 T2 TR 200200169T2
Authority
TR
Turkey
Prior art keywords
inhibitors
tumor metastasis
metastasis
tumor
Prior art date
Application number
TR2002/00169T
Other languages
Unknown language ( )
English (en)
Turkish (tr)
Inventor
Dinarello Charles
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of TR200200169T2 publication Critical patent/TR200200169T2/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/00169T 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı. TR200200169T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL13104799A IL131047A0 (en) 1999-07-22 1999-07-22 Use of il-18 inhibitors

Publications (1)

Publication Number Publication Date
TR200200169T2 true TR200200169T2 (tr) 2002-06-21

Family

ID=11073044

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00169T TR200200169T2 (tr) 1999-07-22 2000-07-17 IL-18 inhibitörlerinin kullanımı.

Country Status (31)

Country Link
US (1) US7741276B2 (enExample)
EP (1) EP1206274B1 (enExample)
JP (1) JP4827352B2 (enExample)
KR (1) KR100682219B1 (enExample)
CN (1) CN1173736C (enExample)
AR (1) AR024907A1 (enExample)
AT (1) ATE363288T1 (enExample)
AU (1) AU782478B2 (enExample)
BG (1) BG65800B1 (enExample)
BR (1) BR0012675A (enExample)
CA (1) CA2380216C (enExample)
CY (1) CY1107932T1 (enExample)
CZ (1) CZ302114B6 (enExample)
DE (2) DE60035049T2 (enExample)
DK (1) DK1206274T3 (enExample)
EA (1) EA005419B1 (enExample)
EE (1) EE04838B1 (enExample)
ES (1) ES2186596T3 (enExample)
HK (1) HK1048248B (enExample)
HU (1) HU228780B1 (enExample)
IL (2) IL131047A0 (enExample)
MX (1) MXPA02000838A (enExample)
NO (1) NO329827B1 (enExample)
NZ (1) NZ516535A (enExample)
PL (1) PL202477B1 (enExample)
PT (1) PT1206274E (enExample)
SK (1) SK287522B6 (enExample)
TR (1) TR200200169T2 (enExample)
UA (1) UA73745C2 (enExample)
WO (1) WO2001007480A2 (enExample)
ZA (1) ZA200200390B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2800450A1 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
EP2357002A1 (en) 2000-10-11 2011-08-17 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
US7718368B2 (en) 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
EA009125B1 (ru) * 2001-05-16 2007-10-26 Йеда Рисерч Энд Дивелопмент Ко., Лтд. Применение ингибиторов il-18 для лечения и/или предупреждения заболеваний, характерных для синдрома системной воспалительной реакции
RU2225720C1 (ru) * 2002-08-12 2004-03-20 Научно-исследовательский институт онкологии Томского научного центра СО РАМН Средство, повышающее противоопухолевую и антиметастатическую активность циклофосфана
JP4563813B2 (ja) * 2002-10-08 2010-10-13 アレス トレーディング ソシエテ アノニム Ｉｌ−１８ｂｐに結合でき、第２サイトカインの活性を阻害するサイトカインの使用
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
ATE557038T1 (de) 2005-06-03 2012-05-15 Ares Trading Sa Herstellung von rekombinantem il-18 bindendem protein
SI1891088T1 (sl) 2005-06-10 2012-02-29 Ares Trading Sa Postopek za äśiĺ äśenje il-18 vezavnega proteina
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
US9812033B2 (en) * 2013-03-06 2017-11-07 Venkatesh R. Chari Tactile graphic display
CA3259975A1 (en) 2022-03-15 2023-09-21 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
TW202432591A (zh) 2023-01-06 2024-08-16 美商拉森醫療公司 抗ｉｌ－１８ｂｐ抗體
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005333A1 (en) * 1992-09-02 1994-03-17 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
AU734756B2 (en) * 1997-03-18 2001-06-21 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use

Also Published As

Publication number Publication date
HU228780B1 (en) 2013-05-28
PL202477B1 (pl) 2009-06-30
MXPA02000838A (es) 2002-07-30
SK882002A3 (en) 2002-07-02
ES2186596T3 (es) 2007-11-16
UA73745C2 (en) 2005-09-15
JP4827352B2 (ja) 2011-11-30
ATE363288T1 (de) 2007-06-15
CN1364086A (zh) 2002-08-14
EE04838B1 (et) 2007-06-15
HK1048248A1 (en) 2003-03-28
EE200200032A (et) 2003-02-17
KR100682219B1 (ko) 2007-02-12
ES2186596T1 (es) 2003-05-16
CY1107932T1 (el) 2013-09-04
AU782478B2 (en) 2005-08-04
HUP0202107A3 (en) 2005-01-28
EP1206274A2 (en) 2002-05-22
DE60035049D1 (de) 2007-07-12
IL131047A0 (en) 2001-01-28
NO329827B1 (no) 2011-01-03
DK1206274T3 (da) 2007-08-13
CA2380216A1 (en) 2001-02-01
EA005419B1 (ru) 2005-02-24
EA200200189A1 (ru) 2002-12-26
NO20020153D0 (no) 2002-01-11
HK1048248B (zh) 2005-04-22
JP2003505472A (ja) 2003-02-12
AU5843200A (en) 2001-02-13
BG106311A (en) 2002-08-30
NO20020153L (no) 2002-03-11
BRPI0012675B1 (pt) 2001-02-01
CN1173736C (zh) 2004-11-03
CA2380216C (en) 2012-01-31
ZA200200390B (en) 2003-04-30
CZ302114B6 (cs) 2010-10-20
BRPI0012675B8 (enExample) 2021-05-25
IL147675A (en) 2009-05-04
WO2001007480A3 (en) 2001-05-10
PT1206274E (pt) 2007-07-06
US7741276B2 (en) 2010-06-22
KR20020027493A (ko) 2002-04-13
SK287522B6 (sk) 2011-01-04
DE60035049T2 (de) 2007-09-27
HUP0202107A2 (en) 2002-10-28
DE1206274T1 (de) 2002-11-14
US20080003216A1 (en) 2008-01-03
AR024907A1 (es) 2002-10-30
NZ516535A (en) 2004-04-30
WO2001007480A2 (en) 2001-02-01
EP1206274B1 (en) 2007-05-30
PL353732A1 (en) 2003-12-01
BG65800B1 (bg) 2009-12-31
CZ2002195A3 (cs) 2002-06-12
BR0012675A (pt) 2002-04-09

Similar Documents

Publication Publication Date Title
DE69907977D1 (de) Pyrrolobenzodiazepine
DE60010098D1 (de) 28-epirapaloge
TR200102711T2 (tr) Kriz halindeki başağrılarının iyileştirilmesinde kullanıma yönelik antikonvülsan türevler
IS6217A (is) Mótefnissameindir með sérvirkni fyrir alfa æxlisdrepboða í mönnum og notkun þeirra
NO20025442D0 (no) Brachyterapi kilde
DE60002193D1 (de) Metalloprotease inhibitoren
TR200200169T2 (tr) IL-18 inhibitörlerinin kullanımı.
EP1320376A4 (en) TREATMENT OF PROSTATE CANCER
NO20014243L (no) Dihetero-substituerte metalloproteaseinhibitorer
DE59806475D1 (de) Urokinase-inhibitoren
PT1242410E (pt) Compostos novos
SE9903290D0 (sv) Novel compounds
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
DE60106850D1 (de) Wälzschleifen von nichtmetallischen Zahnrädern
BR0316544A (pt) Compostos calcilìticos
AU302730S (en) Bed
ATE435200T1 (de) Guanidinophenylalanin-verbindungen als urokinase- inhibitoren
ATE377586T1 (de) Tripeptidylpeptidaseinhibitoren
IS7441A (is) Peptíðdeformýlasatálmar
NO20015922L (no) Nye calpainer og anvendelse derav
ATE433953T1 (de) Peptiddeformylaseinhibitoren
UA50030A (uk) Комплексне добриво
UA32947A (uk) Горілка особлива
SE0004239D0 (sv) New use of an inhibitor
ECSP982458A (es) Aplicación oral de (+)-o- demetiltramadol como analgesico